Report Detail

Pharma & Healthcare Global Immune System Allergy Treatment Market Growth (Status and Outlook) 2022-2028

  • RnM4484353
  • |
  • 22 August, 2022
  • |
  • Global
  • |
  • 103 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Immune System Allergy Treatment is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Immune System Allergy Treatment market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Immune System Allergy Treatment players cover Johnson and Johnson Services, Inc., Sanofi, Allergan plc, Pfizer Inc. and LETIPharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Immune System Allergy Treatment market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Immune System Allergy Treatment market, with both quantitative and qualitative data, to help readers understand how the Immune System Allergy Treatment market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Immune System Allergy Treatment market and forecasts the market size by Type (Allergy Injection and Sublingual Immunotherapy,), by Application (Hospital, Clinic, Pharmacy and Others), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Allergy Injection
Sublingual Immunotherapy

Segmentation by application
Hospital
Clinic
Pharmacy
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Johnson and Johnson Services, Inc.
Sanofi
Allergan plc
Pfizer Inc.
LETIPharma
ALK-Abelló A/S
Allergy Therapeutics
Stallergenes Greer
GlaxoSmithKline plc
Dermapharm Holding

Chapter Introduction
Chapter 1: Scope of Immune System Allergy Treatment, Research Methodology, etc.
Chapter 2: Executive Summary, global Immune System Allergy Treatment market size and CAGR, Immune System Allergy Treatment market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Immune System Allergy Treatment revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Immune System Allergy Treatment revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Immune System Allergy Treatment market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Johnson and Johnson Services, Inc., Sanofi, Allergan plc, Pfizer Inc., LETIPharma, ALK-Abelló A/S, Allergy Therapeutics, Stallergenes Greer and GlaxoSmithKline plc, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Immune System Allergy Treatment Market Size 2017-2028
    • 2.1.2 Immune System Allergy Treatment Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Immune System Allergy Treatment Segment by Type
    • 2.2.1 Allergy Injection
    • 2.2.2 Sublingual Immunotherapy
  • 2.3 Immune System Allergy Treatment Market Size by Type
    • 2.3.1 Immune System Allergy Treatment Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Immune System Allergy Treatment Market Size Market Share by Type (2017-2022)
  • 2.4 Immune System Allergy Treatment Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
    • 2.4.3 Pharmacy
    • 2.4.4 Others
  • 2.5 Immune System Allergy Treatment Market Size by Application
    • 2.5.1 Immune System Allergy Treatment Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Immune System Allergy Treatment Market Size Market Share by Application (2017-2022)

3 Immune System Allergy Treatment Market Size by Player

  • 3.1 Immune System Allergy Treatment Market Size Market Share by Players
    • 3.1.1 Global Immune System Allergy Treatment Revenue by Players (2020-2022)
    • 3.1.2 Global Immune System Allergy Treatment Revenue Market Share by Players (2020-2022)
  • 3.2 Global Immune System Allergy Treatment Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Immune System Allergy Treatment by Regions

  • 4.1 Immune System Allergy Treatment Market Size by Regions (2017-2022)
  • 4.2 Americas Immune System Allergy Treatment Market Size Growth (2017-2022)
  • 4.3 APAC Immune System Allergy Treatment Market Size Growth (2017-2022)
  • 4.4 Europe Immune System Allergy Treatment Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Immune System Allergy Treatment Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Immune System Allergy Treatment Market Size by Country (2017-2022)
  • 5.2 Americas Immune System Allergy Treatment Market Size by Type (2017-2022)
  • 5.3 Americas Immune System Allergy Treatment Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Immune System Allergy Treatment Market Size by Region (2017-2022)
  • 6.2 APAC Immune System Allergy Treatment Market Size by Type (2017-2022)
  • 6.3 APAC Immune System Allergy Treatment Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Immune System Allergy Treatment by Country (2017-2022)
  • 7.2 Europe Immune System Allergy Treatment Market Size by Type (2017-2022)
  • 7.3 Europe Immune System Allergy Treatment Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Immune System Allergy Treatment by Region (2017-2022)
  • 8.2 Middle East & Africa Immune System Allergy Treatment Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Immune System Allergy Treatment Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Immune System Allergy Treatment Market Forecast

  • 10.1 Global Immune System Allergy Treatment Forecast by Regions (2023-2028)
    • 10.1.1 Global Immune System Allergy Treatment Forecast by Regions (2023-2028)
    • 10.1.2 Americas Immune System Allergy Treatment Forecast
    • 10.1.3 APAC Immune System Allergy Treatment Forecast
    • 10.1.4 Europe Immune System Allergy Treatment Forecast
    • 10.1.5 Middle East & Africa Immune System Allergy Treatment Forecast
  • 10.2 Americas Immune System Allergy Treatment Forecast by Country (2023-2028)
    • 10.2.1 United States Immune System Allergy Treatment Market Forecast
    • 10.2.2 Canada Immune System Allergy Treatment Market Forecast
    • 10.2.3 Mexico Immune System Allergy Treatment Market Forecast
    • 10.2.4 Brazil Immune System Allergy Treatment Market Forecast
  • 10.3 APAC Immune System Allergy Treatment Forecast by Region (2023-2028)
    • 10.3.1 China Immune System Allergy Treatment Market Forecast
    • 10.3.2 Japan Immune System Allergy Treatment Market Forecast
    • 10.3.3 Korea Immune System Allergy Treatment Market Forecast
    • 10.3.4 Southeast Asia Immune System Allergy Treatment Market Forecast
    • 10.3.5 India Immune System Allergy Treatment Market Forecast
    • 10.3.6 Australia Immune System Allergy Treatment Market Forecast
  • 10.4 Europe Immune System Allergy Treatment Forecast by Country (2023-2028)
    • 10.4.1 Germany Immune System Allergy Treatment Market Forecast
    • 10.4.2 France Immune System Allergy Treatment Market Forecast
    • 10.4.3 UK Immune System Allergy Treatment Market Forecast
    • 10.4.4 Italy Immune System Allergy Treatment Market Forecast
    • 10.4.5 Russia Immune System Allergy Treatment Market Forecast
  • 10.5 Middle East & Africa Immune System Allergy Treatment Forecast by Region (2023-2028)
    • 10.5.1 Egypt Immune System Allergy Treatment Market Forecast
    • 10.5.2 South Africa Immune System Allergy Treatment Market Forecast
    • 10.5.3 Israel Immune System Allergy Treatment Market Forecast
    • 10.5.4 Turkey Immune System Allergy Treatment Market Forecast
    • 10.5.5 GCC Countries Immune System Allergy Treatment Market Forecast
  • 10.6 Global Immune System Allergy Treatment Forecast by Type (2023-2028)
  • 10.7 Global Immune System Allergy Treatment Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Johnson and Johnson Services, Inc.
    • 11.1.1 Johnson and Johnson Services, Inc. Company Information
    • 11.1.2 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Product Offered
    • 11.1.3 Johnson and Johnson Services, Inc. Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Johnson and Johnson Services, Inc. Main Business Overview
    • 11.1.5 Johnson and Johnson Services, Inc. Latest Developments
  • 11.2 Sanofi
    • 11.2.1 Sanofi Company Information
    • 11.2.2 Sanofi Immune System Allergy Treatment Product Offered
    • 11.2.3 Sanofi Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Sanofi Main Business Overview
    • 11.2.5 Sanofi Latest Developments
  • 11.3 Allergan plc
    • 11.3.1 Allergan plc Company Information
    • 11.3.2 Allergan plc Immune System Allergy Treatment Product Offered
    • 11.3.3 Allergan plc Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Allergan plc Main Business Overview
    • 11.3.5 Allergan plc Latest Developments
  • 11.4 Pfizer Inc.
    • 11.4.1 Pfizer Inc. Company Information
    • 11.4.2 Pfizer Inc. Immune System Allergy Treatment Product Offered
    • 11.4.3 Pfizer Inc. Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Pfizer Inc. Main Business Overview
    • 11.4.5 Pfizer Inc. Latest Developments
  • 11.5 LETIPharma
    • 11.5.1 LETIPharma Company Information
    • 11.5.2 LETIPharma Immune System Allergy Treatment Product Offered
    • 11.5.3 LETIPharma Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 LETIPharma Main Business Overview
    • 11.5.5 LETIPharma Latest Developments
  • 11.6 ALK-Abelló A/S
    • 11.6.1 ALK-Abelló A/S Company Information
    • 11.6.2 ALK-Abelló A/S Immune System Allergy Treatment Product Offered
    • 11.6.3 ALK-Abelló A/S Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 ALK-Abelló A/S Main Business Overview
    • 11.6.5 ALK-Abelló A/S Latest Developments
  • 11.7 Allergy Therapeutics
    • 11.7.1 Allergy Therapeutics Company Information
    • 11.7.2 Allergy Therapeutics Immune System Allergy Treatment Product Offered
    • 11.7.3 Allergy Therapeutics Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Allergy Therapeutics Main Business Overview
    • 11.7.5 Allergy Therapeutics Latest Developments
  • 11.8 Stallergenes Greer
    • 11.8.1 Stallergenes Greer Company Information
    • 11.8.2 Stallergenes Greer Immune System Allergy Treatment Product Offered
    • 11.8.3 Stallergenes Greer Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Stallergenes Greer Main Business Overview
    • 11.8.5 Stallergenes Greer Latest Developments
  • 11.9 GlaxoSmithKline plc
    • 11.9.1 GlaxoSmithKline plc Company Information
    • 11.9.2 GlaxoSmithKline plc Immune System Allergy Treatment Product Offered
    • 11.9.3 GlaxoSmithKline plc Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 GlaxoSmithKline plc Main Business Overview
    • 11.9.5 GlaxoSmithKline plc Latest Developments
  • 11.10 Dermapharm Holding
    • 11.10.1 Dermapharm Holding Company Information
    • 11.10.2 Dermapharm Holding Immune System Allergy Treatment Product Offered
    • 11.10.3 Dermapharm Holding Immune System Allergy Treatment Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 Dermapharm Holding Main Business Overview
    • 11.10.5 Dermapharm Holding Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Immune System Allergy Treatment. Industry analysis & Market Report on Immune System Allergy Treatment is a syndicated market report, published as Global Immune System Allergy Treatment Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Immune System Allergy Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,821.86
5,643.72
3,389.16
6,778.32
560,858.40
1,121,716.80
308,647.80
617,295.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report